Go
View All
[Z15.04] - Genetic susceptibility to malignant neoplasm of endometrium
[Z15.1] - Genetic susceptibility to epilepsy and neurodevelopmental disorders
[Z15.8] - Genetic susceptibility to other disease
[Z15.89] - Genetic susceptibility to other disease
[Z16.1] - Resistance to beta lactam antibiotics
[Z16.11] - Resistance to penicillins
[Z16.13] - Resistance to carbapenem
[Z16.2] - Resistance to other antibiotics
[Z16.21] - Resistance to vancomycin
[Z16.23] - Resistance to quinolones and fluoroquinolones
[Z16.29] - Resistance to other single specified antibiotic
[Z16.30] - Resistance to unspecified antimicrobial drugs
[Z16.32] - Resistance to antifungal drug(s)
[Z16.34] - Resistance to antimycobacterial drug(s)
[Z16.342] - Resistance to multiple antimycobacterial drugs
[Z16.39] - Resistance to other specified antimicrobial drug
[Z17.0] - Estrogen receptor positive status [ER+]
[Z17.2] - Progesterone receptor status
[Z17.22] - Progesterone receptor negative status
[Z17.31] - Human epidermal growth factor receptor 2 positive status
[Z17.4] - Combined receptor status
[Z17.410] - Hormone receptor positive with human epidermal growth factor receptor 2 positive status
[Z17.42] - Hormone receptor negative
[Z17.421] - Hormone receptor negative with human epidermal growth factor receptor 2 negative status
[Z18.0] - Retained radioactive fragments
[Z18.09] - Other retained radioactive fragments
[Z18.10] - Retained metal fragments, unspecified
[Z18.12] - Retained nonmagnetic metal fragments
[Z18.3] - Retained organic fragments
[Z18.32] - Retained tooth
Displaying items 48331 - 48360 of 50340